THU479 FOXA1 Loss Remodels The Tumor Immune Microenvironment In Late-stage Prostate Cancer

Disclosure: L.T. Brea: None. H. Shi: None. V. Keo: None. W. Xie: None. X. Lu: None. G. Gritsina: None. X. Wang: None. S.H. Park: None. J. Zhao: None. J. Yu: None. Background: Castration resistant prostate cancer (CRPC) has shown a poor response to immune checkpoint inhibitors due to its immunosuppre...

Descripción completa

Detalles Bibliográficos
Autores principales: Brea, Lourdes T, Shi, Hongshun, Keo, Viriya, Xie, Wanqing, Lu, Xiaodong, Gritsina, Galina, Wang, Xiaohai, Park, Su H, Zhao, Jonathan, Yu, Jindan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Tumor Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553737/
http://dx.doi.org/10.1210/jendso/bvad114.2107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553737/
http://dx.doi.org/10.1210/jendso/bvad114.2107

Ejemplares similares